ADIAL PHARMACEUTICALS, INC. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Adial Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -256 %, a 9.48% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Return On Equity for 2023 was -183 %, a 1.54% increase from 2022.
  • Adial Pharmaceuticals, Inc. annual Return On Equity for 2022 was -186 %, a 49.3% increase from 2021.
  • Adial Pharmaceuticals, Inc. annual Return On Equity for 2021 was -367 %, a 114% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -183 +2.86 +1.54% Jan 1, 2023 Dec 31, 2023
2022 -186 +181 +49.3% Jan 1, 2022 Dec 31, 2022
2021 -367 -196 -114% Jan 1, 2021 Dec 31, 2021
2020 -171 -80.2 -87.9% Jan 1, 2020 Dec 31, 2020
2019 -91.3 +596 +86.7% Jan 1, 2019 Dec 31, 2019
2018 -687 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.